Phreesia announced its Q2 fiscal year 2024 results, with total revenue increasing by 26% to $85.8 million compared to the same period in the prior year. The average number of healthcare services clients increased by 24% to 3,445. Net loss was $36.8 million, and adjusted EBITDA was negative $11.5 million.
Total revenue increased by 26% to $85.8 million compared to the same period in the prior year.
The average number of healthcare services clients increased by 24% to 3,445 compared to the same period in the prior year.
Healthcare services revenue per AHSC remained relatively flat at $18,268 compared to $18,248 in the same period in the prior year.
Net loss was $36.8 million compared to $46.7 million in the same period in the prior year.
Phreesia is maintaining its revenue outlook for the full fiscal year 2024 at between $353 million and $356 million, implying year-over-year growth of 26% to 27%. They are raising their Adjusted EBITDA outlook for fiscal year 2024 to a range of negative $54 million to negative $49 million from a previous range of negative $60 million to negative $55 million.
Visualization of income flow from segment revenue to net income